Where do NewAmsterdam Pharma Company's ratios come from?

Every ratio is computed from NewAmsterdam Pharma Company's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Profitability
Operating margin	-953.6%-551pp	-1,002.9%-616pp	-575.8%-27.7pp	-270%+2,541pp	-402.5%+2,492pp
Net margin	-942.8%-545pp	-905.7%-375pp	-627.3%-35.2pp	-258.9%+2,831pp	-397.5%+2,935pp
Returns
Return on equity	-29.5%+2.0pp	-28.3%+17.9pp	-39.9%+16.0pp	-28.4%+31.9pp	-31.5%+24.9pp
Return on invested capital	-181.6%—	——	——	——	——
Efficiency
Asset turnover	0×0.0×	0×0.0×	0.1×—	0.1×—	0.1×—
Liquidity
Current ratio	9.8×-10.2×	7.9×-0.2×	12.6×+2.0×	21.1×+11.3×	20×+11.8×
Leverage
Debt-to-equity	0×0.0×	0×0.0×	0×0.0×	0×0.0×	0×0.0×
Valuation
Market capitalization	$3.68B+63.7%	$3.98B+44.6%	$3.2B+114%	$2.07B+19.5%	$2.25B+5.6%
Price / sales	163.1×+115×	176.8×+116×	90.9×+46.4×	32.3×-201×	47.7×-262×
Price / book	5.5×+2.6×	5.8×+2.2×	4.4×+0.5×	2.7×-1.8×	2.9×-2.3×

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about NewAmsterdam Pharma Company.

Connect your AI assistant and get a quick read on the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

Where do NewAmsterdam Pharma Company's ratios come from?: Every ratio is computed from NewAmsterdam Pharma Company's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.